RESMED INC — Director's Dealing 2025

Mar 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-03-10

Reporting Person: Ghoshal Kaushik (Chief Commercial Officer, SaaS)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-10	ResMed Common Stock	M	169	$146.34	Acquired	9894	Direct
2025-03-10	ResMed Common Stock	M	105	$211.76	Acquired	9999	Direct
2025-03-10	ResMed Common Stock	M	3589	$146.34	Acquired	13588	Direct
2025-03-10	ResMed Common Stock	M	5882	$211.76	Acquired	19470	Direct
2025-03-10	ResMed Common Stock	S	9745	$239.3121	Disposed	9725	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-10	ResMed Common Stock Options	$146.34	M	169	Disposed	2026-11-21	ResMed Common Stock (169)	Direct
2025-03-10	ResMed Common Stock Options	$211.76	M	105	Disposed	2027-11-19	ResMed Common Stock (105)	Direct
2025-03-10	ResMed Common Stock Options	$211.76	M	5882	Disposed	2027-11-19	ResMed Common Stock (5882)	Direct
2025-03-10	ResMed Common Stock Options	$146.34	M	3589	Disposed	2026-11-21	ResMed Common Stock (3589)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	9628	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024.

F2: This transaction was executed in multiple trades at prices ranging from $236.62 - $242.73. The price reported above reflects the weighted average sale price.

F3: Represents date options first become exercisable. Options vest 1/3 per year.